1. Home
  2. LMB vs ESPR Comparison

LMB vs ESPR Comparison

Compare LMB & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Limbach Holdings Inc.

LMB

Limbach Holdings Inc.

HOLD

Current Price

$78.85

Market Cap

1.1B

ML Signal

HOLD

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$2.42

Market Cap

793.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMB
ESPR
Founded
1901
2008
Country
United States
United States
Employees
1400
N/A
Industry
Engineering & Construction
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
793.7M
IPO Year
2014
2013

Fundamental Metrics

Financial Performance
Metric
LMB
ESPR
Price
$78.85
$2.42
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$130.00
$7.60
AVG Volume (30 Days)
163.2K
4.1M
Earning Date
06-10-2026
05-28-2026
Dividend Yield
N/A
N/A
EPS Growth
25.68
60.71
EPS
3.23
N/A
Revenue
$646,804,000.00
$403,135,000.00
Revenue This Year
$16.50
$0.69
Revenue Next Year
$4.76
$10.67
P/E Ratio
$24.63
N/A
Revenue Growth
24.68
21.31
52 Week Low
$63.02
$0.73
52 Week High
$154.04
$4.18

Technical Indicators

Market Signals
Indicator
LMB
ESPR
Relative Strength Index (RSI) 39.19 27.96
Support Level $77.96 $2.36
Resistance Level $85.30 $3.02
Average True Range (ATR) 6.07 0.18
MACD -1.57 -0.08
Stochastic Oscillator 13.94 0.16

Price Performance

Historical Comparison
LMB
ESPR

About LMB Limbach Holdings Inc.

Limbach Holdings Inc is a commercial specialty contractor in the fields of heating, ventilation, air conditioning, plumbing, electrical, and building controls for the design and construction of new and renovated buildings, maintenance services, energy retrofits, and equipment upgrades. It operates in two segments namely General Contractor Relationships (GCR) and Owner Direct Relationships (ODR). The company generates maximum revenue from the ODR segment.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: